https://www.nature.com/articles/s41392-021-00679-0
Cytokine-based interventions
The current treatment for CS is mainly based on traditional anti-inflammatory drugs such as the administration of corticosteroids, chloroquine, and colchicines.210,211 Recently, biologics like recombinant cytokines; monoclonal antibodies against IL-6, IL-1β, TNF-α, and IFN-γ; and signaling pathway inhibitors are also available or in the pipeline for production. In this and the next section, we aim to discuss the key biologics that are currently or potentially applied to treat CS (Fig. 6).
- Forums
- ASX - By Stock
- NSB
- Ann: Results from Pulmonary Studies
Ann: Results from Pulmonary Studies, page-39
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.001(2.56%) |
Mkt cap ! $5.784M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.6¢ | $5.263K | 142.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20181 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 125000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20181 | 0.036 |
3 | 428000 | 0.035 |
1 | 33332 | 0.030 |
2 | 108800 | 0.026 |
1 | 39900 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 125000 | 1 |
0.042 | 27998 | 1 |
0.046 | 25000 | 1 |
0.050 | 1086 | 1 |
0.051 | 75976 | 1 |
Last trade - 15.40pm 28/06/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online